Redirecting to original paper in 30 seconds...

Click below to go immediately or wait for automatic redirect

arxiv_ai 96% Match Research Paper Cheminformaticians,Drug Discovery Scientists,Analytical Chemists,AI Researchers 1 week ago

Test-Time Tuned Language Models Enable End-to-end De Novo Molecular Structure Generation from MS/MS Spectra

generative-ai › diffusion
📄 Abstract

Abstract: Tandem Mass Spectrometry enables the identification of unknown compounds in crucial fields such as metabolomics, natural product discovery and environmental analysis. However, current methods rely on database matching from previously observed molecules, or on multi-step pipelines that require intermediate fragment or fingerprint prediction. This makes finding the correct molecule highly challenging, particularly for compounds absent from reference databases. We introduce a framework that, by leveraging test-time tuning, enhances the learning of a pre-trained transformer model to address this gap, enabling end-to-end de novo molecular structure generation directly from the tandem mass spectra and molecular formulae, bypassing manual annotations and intermediate steps. We surpass the de-facto state-of-the-art approach DiffMS on two popular benchmarks NPLIB1 and MassSpecGym by 100% and 20%, respectively. Test-time tuning on experimental spectra allows the model to dynamically adapt to novel spectra, and the relative performance gain over conventional fine-tuning is of 62% on MassSpecGym. When predictions deviate from the ground truth, the generated molecular candidates remain structurally accurate, providing valuable guidance for human interpretation and more reliable identification.
Authors (4)
Laura Mismetti
Marvin Alberts
Andreas Krause
Mara Graziani
Submitted
October 27, 2025
arXiv Category
cs.AI
arXiv PDF

Key Contributions

This paper introduces a framework for end-to-end de novo molecular structure generation from MS/MS spectra using test-time tuning (TTT) of pre-trained transformer models. This approach bypasses manual annotations and intermediate steps, surpassing state-of-the-art methods like DiffMS on popular benchmarks.

Business Value

Accelerates drug discovery and natural product identification by enabling faster and more accurate elucidation of unknown molecular structures from spectral data.